Advertisement

Intensive Care Medicine

, Volume 29, Issue 12, pp 2230–2238 | Cite as

Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU

  • Claudia D. SpiesEmail author
  • Hilke E. Otter
  • Bernd Hüske
  • Pranav Sinha
  • Tim Neumann
  • Jordan Rettig
  • Erika Lenzenhuber
  • Wolfgang J. Kox
  • Edward M. Sellers
Original

Abstract

Objective

To examine the effect of bolus vs. continuous infusion adjustment on severity and duration of alcohol withdrawal syndrome (AWS), the medication requirements for AWS treatment, and the effect on ICU stay in surgical intensive care unit (ICU) patients.

Design and setting

Prospective randomized, double-blind controlled trial in a surgical ICU.

Patients

44 patients who developed AWS after admission to the ICU.

Interventions

Patients were randomized to either (a) a continuous infusion course of intravenous flunitrazepam (agitation), intravenous clonidine (sympathetic hyperactivity), and intravenous haloperidol (productive psychotic symptoms) if needed (infusion-titrated group), or (b) the same medication (flunitrazepam, clonidine, or haloperidol) bolus adjusted in response to the development of the signs and symptoms of AWS (bolus-titrated group).

Measurements and results

The administration of “as-needed” medication was determined using a validated measure of the severity of AWS (Clinical Institute of Withdrawal Assessment). Although the severity of AWS did not differ between groups initially, it significantly worsened over time in the infusion-titrated group. This required a higher amount of flunitrazepam, clonidine, and haloperidol. ICU treatment was significantly shorter in the bolus-titrated group (median difference 6 days) due to a lower incidence of pneumonia (26% vs. 43%).

Conclusions

We conclude that symptom-orientated bolus-titrated therapy decreases the severity and duration of AWS and of medication requirements, with clinically relevant benefits such as fewer days of ventilation, lower incidence of pneumonia, and shorter ICU stay.

Keywords

Alcohol withdrawal syndrome Symptom-orientated therapy Surgical intensive care unit Clinical Institute of Withdrawal Assessment Critically ill patients Pneumonia 

Notes

Acknowledgements

We are most grateful to our statistician Dipl.-Math Gerda Siebert, Institute of Medical Biometrics, Department of Medical Statistics, Charité Medical Center, Humboldt University of Berlin.

Supplementary material

134_2003_2033_MOESM1_ESM.pdf (30 kb)
Supplementary material (PDF 30 KB)

References

  1. 1.
    Moore R, Bone L, Geller G (1989) Prevalence, detection and treatment of alcoholism in hospitalised patients. JAMA 261:403–407CrossRefPubMedGoogle Scholar
  2. 2.
    Spies C, Tonnesen H, Andreasson S, Helander A, Conigrave K (2001) Perioperative morbidity and mortality in chronic alcoholics. Alcohol Clin Exp Res 25:164–170CrossRefGoogle Scholar
  3. 3.
    Spies C, Rommelspacher H (1999) Novel aspects of alcohol withdrawal in the surgical patient–prevention and treatment. Anesth Analg 88:946–954CrossRefPubMedGoogle Scholar
  4. 4.
    Tonnesen H, Kehlet H (1999) Preoperative alcoholism and postoperative morbidity. Br J Surg 86:869–874CrossRefPubMedGoogle Scholar
  5. 5.
    Spies CD, Neuner B, Neumann T, Blum S, Müller C, Rommelsbacher H, Sanft C, Specht M, Hannemann L, Striebel HW, Schaffartzik W (1996) Intercurrent complications in chronic alcoholics admitted to the intensive care unit following trauma. Intensive Care Med 22:286–293CrossRefPubMedGoogle Scholar
  6. 6.
    Spies C, Nordmann A, Brummer G, Marks C, Conrad CA, Berger G, Runkel N, Neumann T, Müller C, Rommelspacher H, Specht M, Hannemann L, Striebel HW, Schaffartzik W (1996) Intensive care unit stay is prolonged in chronic alcoholic men following tumor resection of the upper digestive tract. Acta Anaesthesiol Scand 40:649–656CrossRefPubMedGoogle Scholar
  7. 7.
    Saitz R, Mayo-Smith M, Roberts M, Redmond H, Bernard D, Calcins D (1994) Individualized treatment for alcohol withdrawal. JAMA 272:519–523CrossRefPubMedGoogle Scholar
  8. 8.
    Sullivan JT, Sykora K, Schneidermann J, Naranjo CA, Sellers EM (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIVAA-Ar). Br J Addict 84:1353–1357CrossRefPubMedGoogle Scholar
  9. 9.
    Spies C, Morciniec P, Lenzenhuber E, Müller C, Marks C, Helling K, Runkel N, Berger G, Blum S, Rommelspacher H (1998) β-Carbolines in alcohol dependent intensive care patients during prophylactics and therapy of alcohol withdrawal syndrome. Addict Biol 3:281–294CrossRefPubMedGoogle Scholar
  10. 10.
    Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. JAMA 278:144–151CrossRefPubMedGoogle Scholar
  11. 11.
    Spies C, Dubisz N, Neumann T, Blum S, Müller C, Rommelspacher H, Brummer G, Specht M, Sanft C, Hannemann L, Striebel HW, Schaffartzik W (1996) Therapy of alcohol withdrawal syndrome in intensive care patients following trauma: results of a prospective, randomized trial. Crit Care Med 24:414–422CrossRefPubMedGoogle Scholar
  12. 12.
    Imdahl H, Imdahl A (1992) Prophylaxe und Therapie des Alkoholentzugsdelirs in der Chirurgie—eine Fragebogenanalyse. Aktulle Chir 27:139–143Google Scholar
  13. 13.
    Kress JP, Pohlmann AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically III patients undergoing mechanical ventilation. N Engl J Med 342:1471–1477CrossRefPubMedGoogle Scholar
  14. 14.
    Boulain T (1998) Unplanned extubations in the adult intensive care unit: a prospective multicenter study. Assoscation des Reanimateurs du Centre-Ouest. Am J Respir Crit Care Med 157:1131–1137CrossRefPubMedGoogle Scholar
  15. 15.
    Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ (2000) Sedation in the intensive care unit: a systematic review. JAMA 283:1451–1459CrossRefPubMedGoogle Scholar
  16. 16.
    Lenzenhuber E, Müller C, Rommelspacher H, Spies C (1999) Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between two symptom-oriented therapeutic concepts. Anaesthesist 48:89–96CrossRefPubMedGoogle Scholar
  17. 17.
    Spies C, Dubisz N, Funk W, Blum S, Müller C, Rommelspacher H, Brummer G, Specht M, Hannemann L, Striebel HW, Schaffartzik W (1995) Prophylaxis of alcohol withdrawal syndrome in alcohol dependent patients admitted to the intensive care unit following tumour resection. Br J Anaesth 75:734–739CrossRefPubMedGoogle Scholar
  18. 18.
    Task Force on DSM-IV (1994) Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). American Psychiatric Association, Washington, pp 173–177Google Scholar
  19. 19.
    Badawy AA, Rommelspacher H, Morgan CJ, Bradley DM, Bonner A, Ehlert A, Blum S, Spies C (1998) Tryptophan metabolism in alcoholism: tryptophan but not excitatory amino acid availability to the brain is increased before the appearance of the alcohol-withdrawal syndrome in men. Alcohol Alcohol 33:616–625CrossRefPubMedGoogle Scholar
  20. 20.
    Spies CD, von Winterfeld A, Müller C, Rommelspacher H, Neumann T, Marks C, Berger G, Conrad C, Blum S, Hannemann L, Striebel HW, Schaffartzik W (1996) Reliability of carbohydrate-deficient transferrin to detect chronic alcohol misuse in carcinoma patients. Eur Addict Res 2:156–162CrossRefGoogle Scholar
  21. 21.
    Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R (1974) Controlled sedation with alphaxalone-alphadolone. BMJ 2:656–659CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Otter H, Spies C (2003) Analgosedierung und Entzugssyndrom. In: Kox WJ, Spies D (eds) Check-up Anästhesiologie. Springer, Berlin Heidelberg New York, pp 370–378Google Scholar
  23. 23.
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1998) CDC definitions for nosocomial infections. Am J Infect Control 16:128–140CrossRefGoogle Scholar
  24. 24.
    American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRefGoogle Scholar
  25. 25.
    Brown C, Albrecht R, Pettit H, McFadden, Schermer C (2000) Opioid and benzodiazepin withdrawal syndrome in adult burn patients. Am Surg 66:367–371PubMedGoogle Scholar
  26. 26.
    Tobias JD (2000) Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med 28:2122–2132CrossRefPubMedGoogle Scholar
  27. 27.
    Atkins PM, Mion LC, Mendelson W, Palmer RM, Slomka J, Franko T (1997) Characteristics and outcomes of patients who self-extubated from ventilatory support: a case-control study 122:1317–1323Google Scholar
  28. 28.
    Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J (1999) Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 160:608–613CrossRefPubMedGoogle Scholar
  29. 29.
    Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Augusti-Vidal A (1998) Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 93:318–342CrossRefGoogle Scholar
  30. 30.
    Cross AS, Roup B (1981) Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 70:681–685CrossRefPubMedGoogle Scholar
  31. 31.
    Rodriguez JL (1994) Hospital-acquired gram-negative pneumonia in critically ill, injured patients. Am J Surg 165:34S-42SCrossRefGoogle Scholar
  32. 32.
    Eggers V, Schilling A, Kox WJ, Spies C (2003) Septic encephalopathy. Diagnosis und therapy. Anaesthesist 52:294–303CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Claudia D. Spies
    • 1
    Email author
  • Hilke E. Otter
    • 1
  • Bernd Hüske
    • 1
  • Pranav Sinha
    • 2
  • Tim Neumann
    • 1
  • Jordan Rettig
    • 3
  • Erika Lenzenhuber
    • 4
  • Wolfgang J. Kox
    • 1
  • Edward M. Sellers
    • 5
  1. 1.Department of Anesthesiology and Intensive Care MedicineCharité-Universitätsmedizin Berlin, Campus Charité MitteBerlinGermany
  2. 2.Institute of Clinical ChemistryCharité-Universitätsmedizin BerlinBerlinGermany
  3. 3.School of MedicineUniversity of ConnecticutUSA
  4. 4.Department of Anesthesiology and Intensive Care MedicineCharité-Universitätsmedizin Berlin, Campus Benjamin Franklin BerlinGermany
  5. 5.Departments of Pharmacology, Medicine, and PsychiatryUniversity of TorontoTorontoCanada

Personalised recommendations